Fascin is over-expressed in esophageal squamous cell carcinoma (ESCC) and involved in the proliferation and invasiveness of ESCC cells. In this study, we retrospectively examined the expression of fascin in ESCC samples by immunohistochemistry and revealed that over-expression of fascin was related to poor patient survival. RNAi-mediated knockdown of fascin in ESCC cells significantly inhibited cell proliferation and invasiveness, whereas forced expression of fascin in immortalized esophageal epithelial cells accelerated cell proliferation and invasiveness. To explore the underlying mechanism, cDNA microarray was performed to identify the differential gene expression profiles between a fascin-depleted cell line by RNAi and the corresponding control ESCC cells. Results showed that 296 genes were differentially expressed upon fascin depletion. In this study, we focused on two down-regulated genes: CYR61 and CTGF. We found that restored expression of either CYR61 or CTGF led to a recovery of the suppression of cellular proliferation and invasiveness induced by down-regulation of fascin expression; the protein level of CYR61 and CTGF were up-regulated in ESCCs and their expression pattern correlated with fascin over-expression. Finally, analysis of signal transduction revealed that fascin affected the expressions of CYR61 and CTGF through TGF-β pathway.
Introduction
Esophageal cancer has the poorest prognosis among the malignant tumors of digestive tract. Despite advancements in multimodal therapy, the overall 5-year survival rate for patients with esophageal squamous cell carcinoma (ESCC) remains poor (1, 2) . In an effort to improve prognosis of ESCC, several molecular markers, such as interleukin 6 and MMP-12, have been identified (3, 4) . However, the molecular mechanisms underlying esophageal carcinogenesis still remain largely unknown. Fascin, an actin-bundling protein has recently been implicated in a variety of tumors including ESCC, which promoted our investigation.
Fascin is normally expressed in the mesenchymal tissues and nervous system (5) . It is reported to function by forming parallel actin bundles in either lamellipodial or filopodial cell protrusions, which are key cellular structures for environmental guidance and cell migration (6, 7) . Aberrant fascin expression has been reported in various human carcinomas such as colon cancer and gastric cancer (8, 9) . Fascin is over-expressed in ESCCs, and its increased expression is associated with a poor prognosis (10) . Our previous study reported the over-expression of fascin in the early stage of ESCC progression, which facilitated the proliferation and invasiveness of cancer cells (11, 12) . However, the molecular basis of fascin function in the progression of ESCC remains largely unknown.
In this study, firstly, we retrospectively examined the expression of fascin in large amounts of ESCC tissue samples by immunohistochemistry, and showed that over-expression of fascin was related to the poor survival of ESCC patients. RNAi-mediated knockdown of fascin in ESCC cells significantly inhibited cell proliferation and invasiveness, whereas forced expression of fascin in immortalized esophageal epithelial cells accelerated cell proliferation and invasiveness. Then, to explore the mechanism underlying the effects of fascin in ESCCs, we utilized cDNA microarrays to analyze gene expression profiles in PSC cells (ESCC cells that express high levels of fascin) and PSF8 cells (fascin-depleted ESCC cells) (11) . Several differentially expressed genes have been identified and categorized based on their biological function. Specially, the proliferation-and invasiveness-related genes were predominantly represented. The data of cDNA array has been validated by real-time RT-PCR, western blotting, and immunofluorescence analyses. As a result, we focused on two down-regulated genes: CYR61 (Cysteine-rich, angiogenic inducer 61) and CTGF (Connective tissue growth factor), both of which were CCN (CYR61/CTGF/NOV) members (13) . Further studies demonstrated that CYR61 and CTGF were directly involved in fascin-mediated proliferation and invasiveness of ESCC cells. Additionally, we also revealed that fascin might affect the expressions of CYR61 and CTGF via TGF-β signaling pathway.
Materials and methods

Tissue specimens and immunohistochemical staining
Surgically removed tumors embedded in paraffin wax blocks from 198 ESCC cases were retrieved from the archives of the Department of Pathology of the Central Hospital of Shantou City, P.R. China.
The cases were received between 1987 and 1997. The cases were selected in this study only if a follow-up was obtained and clinical data were available. Mean age at surgery was 53 years (range , and 138 patients were male and 60 were female. All specimens were fixed in 10% formaldehyde solution, embedded in paraffin blocks, and then cut into 4-μm sections.
Immunohistochemical staining was performed as described (14) . The SuperPicTure Polymer Detection kit and the Liquid Substrate kit (Invitrogen, Carlsbad, USA) were used to perform immunohistochemistry according to the manufacturer's instructions. Each section was independently assessed by two histopathologists without prior knowledge of patient data.
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The expression was scored based on intensity and the rate of the positive cells. The intensity was graded as follows: 0, negative; 1, weak; 2, moderate; 3, strong. The rate of positive cells was defined as: 0, <5%; 1, 5~25%; 2, 26~50%; 3, 51%~75%; 4, >75%. The final score was calculated by multiplying the intensity grade and the rate of positive cells producing a total range of 0-12. For statistical analyses, scores of 0-4 were considered "-", scores of 5-8 were considered "+", scores of 9-12 were considered "++". "+~++" was defined as positive staining and "++" was defined as "over-expression".
The study was approved by the ethical committee of the Central Hospital of Shantou City and the ethical committee of the Medical College of Shantou University, and written informed consent was obtained from all surgical patients to use resected samples for research.
Cell lines and cell culture
SHEE cells (immortal embryonic esophageal epithelium) and KYSE150 cells (ESCC cell line)
were maintained in DMEM medium (Invitrogen) containing 10% fetal calf serum (15, 16) . Other three human ESCC cell lines, PSF8, PSF10 and PSC, were established in our laboratory (11) . These cell lines were derived from EC109 cells, an ESCC cell line with high fascin expression (11, 17) . The PSF8 and PSF10 cell lines were derived from EC109 cells that were stably transfected with different fascin-siRNAs, and the PSC cell line were derived from EC109 cells stably transfected with empty vector. These cells were maintained in 199 medium (Invitrogen) containing 10% fetal calf serum in the absence or presence of 200μg/ml G418.
Antibodies and western blotting
Total cell lysates were prepared in RIPA buffer, separated by SDS-PAGE and transferred to PVDF membranes (Millipore, Billerica, USA). The membranes were incubated in blocking buffer and then incubated with the indicated antibody. Finally, immunoreactive bands were revealed using luminol reagent (Santa Cruz Biotechnology, Delaware, USA). Photography and quantitative analyses were done using the FluorChemTMIS-8900 (Alpha Innotech). The following antibodies were used: mouse anti-fascin (DAKO Corporation, Glostrup, Denmark), goat anti-Smad2/3, rabbit anti-p-Smad2/3 (Santa Cruz Biotechnology), mouse anti-β-actin (Sigma, Saint Louis, USA), rabbit anti-CYR61 (Novus, Littleton, USA), mouse anti-CTGF, mouse anti-THBS1 (R&D, Minneapolis, USA), rabbit anti-DSC2 (ARP, Belmont, USA) and rabbit anti-ATF3 (Rockland, Gilbertsville, USA). Detailed information about the antibodies was listed in Table 1 .
RNAi-mediated knockdown of fascin in KYSE150 cells
Two siRNA expressing plasmids containing different siRNA were used (11) . KYSE150 cells were transfected with these plasmids using SuperFect reagent (QIAGEN, Germantown, USA). Cells were harvested 48 h later and used for further analysis.
Expression fascin in SHEE cells and expression of CYR61 and CTGF in the fascin-depleted cells
To generate the fascin expression vector, the open reading frame of human fascin cDNA was cloned into the eukaryotic expression vector pcDNA3.0 (Invitrogen). The pcDNA3/fascin plasmid or empty pcDNA3 vector was transfected into SHEE cells using SuperFect reagent. Cells were harvested 48 h later and used for further analysis.
For CYR61 and CTGF expression, PSF8 cells were transfected with the expression plasmid (pcDNA3/CYR61 or pcDNA3/CTGF) (18, 19) and used for real-time RT-PCR analysis, BrdU incorporation assay and invasiveness assay 48 h after transfection.
BrdU incorporation assay
BrdU incorporation assay was performed by using the 5-Bromo-2´-deoxy-uridine Labeling and Detection Kit (Roche, Penzberg, Germany) according to the manufacturer's instructions. Slides for immunostaining were counterstained with the nucleophilic dye 4', 6-diamidino-2-phenyl-indole (DAPI, Sigma). Cells were analyzed by microscopy, and the means of cells with BrdU incorporation were calculated.
Cell invasiveness assay and chamber migration assay
Invasiveness assay and migration assay were performed as described before (11) . For invasiveness,
1×10
5 cells were seeded onto the top chamber of a 24-well matrigel-coated membrane with 8-μm pores (Millipore), and the bottom chamber was filled with 199 medium with 10% fetal calf serum (in the migration assay, cells were directly seeded on an uncoated chamber). The membranes were fixed and stained by Giemsa reagent and invasiveness and migration were quantified by counting 10 random fields under a light microscope (400×). The mean value was calculated from data obtained from three separate chambers.
cDNA microarray analysis
Affymetrix GeneChip Human genome U133 plus 2.0 arrays (Affymetrix, Santa Clara, USA) containing 39,000 known genes and expressed sequence tags were used in this study. Total RNA from PSF8 and PSC cells was isolated (11) . RNA of three independent samples of each cell line was mixed as a RNA pool and quantified spectrophotometrically. Preparation of double-stranded cDNAs, biotin-labeled cRNA targets, hybridization, washing, staining, subsequent scanning of the hybridized array and data processing were performed according to the Affymetrix recommendations. The ratio of the geometric means of the expression intensities for each gene fragment was calculated and reported in terms of the fold change (up or down) relative to the control. The differentially expressed genes were identified from a single experiment and further validated in two fascin-depleted cell lines. The data have been deposited in GEO (accession number: GSE11373).
Fluorescence staining
Fluorescence staining was performed as described (12) . Briefly, cells were fixed and treated with 0.2% (v/v) Triton X-100, and subsequently incubated in goat serum. Primary antibody was then added and incubated overnight at 4°C followed by incubation with FITC-labeled secondary antibody for 30 min at 37°C. Finally, the cells were mounted and examined using a fluorescence microscope (Olympus, CKX41).
Real-time Reverse Transcription (RT)-PCR
Total cellular RNA was extracted from cells with TRIzol reagent (Invitrogen) and reverse transcribed to cDNA using the PrimeScript TM RT-PCR kit (TaKaRa, Dalian, China). The real-time RT-PCR assay was performed with the Rotor-Gene 6000 system(Corbett Life Science, Sydney, Australia) using SYBR Premix Ex Taq (TaKaRa) according to the manufacturer's instructions. All reactions were done in triplicate. The absolute levels of mRNAs of genes were normalized to that of GAPDH mRNA. The relative value from the vehicle-treated control group was considered equal to one arbitrary unit.
Primers used in the real-time RT-PCR assay were listed in Table 2 .
Treatment with r-hTHBS1 and TGF-β1
EC109 and PSF8 cells were seeded into 6-well plates at 2×10 5 cells/well and cultured for 12 h. The cells were then serum-starved overnight followed by incubation with r-hTHBS1 (200 or 400ng/ml, R&D, Minneapolis, USA) or TGF-β1 (10ng/ml, Invitrogen), respectively. Cells were harvested after different times of treatment and used for further analysis.
Statistical analysis
Comparisons between data sets were performed using the χ 2 test and t test when appropriate. The correlation of fascin expression with CYR61 and CTGF expression was addressed by the Kappa test.
Survival was assessed by Kaplan-Meier analysis with log-rank score for determining statistical significance. Relative risk was evaluated by the multivariate Cox proportional hazards model. P < 0.05 was used to determine statistical significance. All statistical tests were performed with SPSS statistic software (SPSS ® 13.0 by SPSS Inc).
Results
Over-expression of fascin was related to poor survival of ESCC patients
Our previous study has shown that fascin was up-regulated in ESCC (12) . Here, we further confirmed the over-expression of fascin (++) in ESCCs by immunohistochemical staining ( Figure 1A , B, C and D). Kaplan-Meier survival analysis was employed to evaluate the association between fascin expression and the overall survival. Result of the statistical analysis demonstrated that over-expression of fascin was associated with decreased overall survival. Patients without fascin over-expression had a 5-year survival of 46.5%, compared with 30.6% for fascin over-expressing patients (P=0.005) ( Figure   1E ). Moreover, we performed multivariate analysis to assess the independent predictive value of fascin expression for overall survival, and the risk ratio for fascin over-expressing patients was 1.795 (P=0.004) ( Table 3) .
Effects of fascin expression on cell proliferation and invasiveness
Our previous work has shown that siRNA-mediated knockdown of fascin in EC109 cells (an ESCC cell line) led to decreased cellular proliferation and invasiveness (11). Here we further confirmed these results by RNAi in KYSE150 cells, another ESCC cell line. Western blotting results revealed that two siRNA-treated cell clones showed markedly decrease of fascin expression level compared with the control cells (Figure 2A ). The two clones were then used for further studies. The effect of fascin depletion on cell proliferation was evaluated by BrdU incorporation assay. We found that siRNA-treated KYSE150 cells showed less BrdU incorporation than control cells, indicating that depletion of fascin in ESCC cells inhibited cell proliferation ( Figure 2B ). The motility of siRNA-treated clones was examined by migration assay, and the migration rates of siRNA-treated cells were decreased as compared with the control ( Figure 2C ). Furthermore, Fascin depletion also dramatically reduced the invasive capability of ESCC cells ( Figure 2D ).
In addition, we overexpressed fascin in SHEE cells, an immortalized esophageal epithelial cell line which had low fascin level (20) , and then determined the effect exerted by forced expression of fascin on cell proliferation and invasiveness. We identified two fascin-transfected SHEE clones with high expression of fascin by western blotting ( Figure 3A 
Genes differentially expressed upon fascin knockdown
To explore the mechanism through which fascin influences the proliferation and invasiveness of ESCC cells, we selected PSF8 (fascin-depleted) and PSC (fascin high-expressed), two ESCC cell lines recently established in our laboratory for cDNA microarray analysis, and identified genes that were differentially expressed upon fascin knockdown. Among 39,000 genes examined, 296 were differentially expressed to a significant degree (≥2-fold difference between PSF8 and PSC samples).
Specifically, 78 genes were down-regulated and 218 genes were up-regulated upon fascin knockdown.
The intensities of gene expression signals revealed that 46 genes showed ≥10-fold difference in expression levels between the PSF8 set and the control set, 41 gene fragments demostrated ≥5-fold to 10-fold difference, and 209 gene fragments had ≥2-fold to 5-fold difference in expression levels between the two cells.
To determine roles of these differentially expressed genes, they were categorized based on biological functions, including cell adhesion, invasiveness, apoptosis and proliferation, transcription, and cell signaling ( Table 4) .
Validation of the microarray data
To confirm the microarray data, real-time RT Based on these analyses, we focused on two proliferation-and invasiveness-related genes, CTGF and CYR61 due to the following reasons. First, both CYR61 and CTGF are TGF-β-targeted genes (21, 22 ) that were reported to participate in the proliferation and invasiveness of various cancer cells (23) .
Second, both of them are secreted proteins belonging to CCN family (13) .
Correlation between fascin expression and the protein levels of CYR61 and CTGF in ESCCs
To explore whether there is a correlation between the expression of fascin and CYR61 or CTGF, the expression patterns of their protein products were determined by immunohistochemical staining of 80
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ESCC specimens and 50 normal esophageal mucosas.
Positive cytoplasmic immunostaining of CTGF and CYR61 protein was observed in both cancerous and normal mucosa of the esophagus. In ESCC samples, most of the cancer cells showed intense immunostaining signals of the two proteins, whereas only negligible or weak positive signals were detected in the normal epithelium of the esophagus (Figure 5A-C) . Positive rate (+~++) of CTGF and CYR61 proteins was higher in ESCC samples than in normal mucosa (Table 5) .
We also identified a positive correlation between the protein level of fascin and CTGF (r = 0.557; P 
CYR61 and CTGF were involved in the fascin-mediated cell proliferation and invasiveness of ESCC cells
The data from clinical studies suggested that CYR61 and CTGF might mediate the function of fascin in ESCC. To further address this issue, we explore the function of the two genes in ESCC cells.
Our previous study reported that CTGF was involved in the tumorigenicity of ESCC cells (19) ; however, the role of CYR61 in ESCC remained unknown. By using RNAi method, we found that CYR61 knockdown led to decreased proliferation and invasiveness of ESCC cells (Supplemental Then, to find whether CYR61 and CTGF were directly involved in fascin-induced alterations in cell proliferation and invasiveness, we transfected PSF8 cells with CYR61-expressing or CTGF-expressing plasmid, respectively. Real-time RT-PCR analysis showed that the expressions of both CTGF and CYR61 were restored in the transfected PSF8 cells ( Figure 6A and B) . Moreover, BrdU incorporation assay and invasiveness assay revealed that the elevated expression of CTGF or CYR61 resulted in partial recoveries of cellular proliferation and invasiveness. Cell proliferated rates of CYR61-and CTGF-restored cells recovered by about 67% and 51%, and their invasiveness recovered by about 70%
and 53%, respectively ( Figure 6C and D) .
Fascin affected the expressions of CYR61 and CTGF via TGF-β pathway
It has been reported that CYR61 and CTGF were target genes of TGF-β (21, 22) . To examine whether this is the same case in ESCC cells, we treated EC109 cells with TGF-β1, and found that the level of p-Smad2/3, CTGF and CYR61 were up-regulated in a time-dependent manner ( Figure 7A and B). Based on this result, we proposed that fascin might affect the expressions of CTGF and CYR61 via TGF-β pathway. Thus we examined the activation status of this pathway by detecting the phosphorylation of Smad2/3 in fascin-depleted cells by western blotting, and found that the level of p-Smad2/3 was decreased in the fascin-depleted cells ( Figure 7C ). These results suggested that fascin might affect the expressions of CYR61 and CTGF via TGF-β pathway.
To assess whether the suppression of TGF-β pathway mediated by fascin down-regulation was responsible for the decreased invasive capability of PSF8 cells, we tested the effects of TGF-β1 on the invasive capability of EC109 cells and PSF8 cells. By invasiveness assay, we found that treatment with TGF-β1 not only significantly facilitated the invasiveness ability of EC109 cells, but also resulted in the recovery of the invasiveness ability of PSF8 cells ( Figure 7D ). However, the invasiveness of PSF8 cells was still lower than that of EC109 cells, even in the presence of TGF-β1. Thus, we reasoned that fascin-mediated alteration in cell invasiveness was related to activation of TGF-β pathway.
Fascin altered the activation of TGF-β pathway through THBS1
Our microarray data showed that THBS1, an activator of the TGF-β pathway (25) 
Discussion
The involvement of fascin in cellular proliferation and invasiveness has been reported in a variety of cancers including ESCC (8) (9) (10) (11) (12) . In this study, the retrospective analysis of a large amount of ESCC samples further proved that fascin was over-expressed in ESCCs and revealed that over-expression of fascin was related to poor survival. At the cellular level, we showed that RNAi-mediated knockdown of fascin in ESCC cells significantly inhibited cellular proliferation and invasiveness, whereas forced expression of fascin in immortalized esophageal epithelial cells accelerated cellular proliferation and invasiveness. Combined with our previous findings of fascin (11, 12) , all the results strongly suggested that fascin was involved in the development and progression of ESCC.
It has been reported that the roles of fascin in carcinoma cells are mediated either by increasing the formation or functional effectiveness of cell protrusions, or by the binding of phosphorylated fascin to active PKC (26) . However, the mechanism underlying the oncogenic effect of fascin has not been fully understood. Here, we demonstrated that upon fascin knockdown, the expression of several cell invasiveness-related genes and cell proliferation-related genes was altered, implicating they might mediate the effect of fascin in cell proliferation and invasiveness. Further analysis suggested that fascin depletion led to down-regulation of certain genes that stimulate/promote cellular invasiveness and proliferation, such as CTGF, CYR61 and THBS1 (23, 27) , as well as up-regulation of certain genes that inhibit invasiveness or proliferation, such as ATF3 and DSC2 (28, 29) . Moreover, expression of certain transcription factors and signal molecules such as ID3 and FOS were also altered in the fascin-depleted cells, indicating that fascin might affect a complex network that contributes to tumorigenisis and progression.
Among these differentially expressed genes, CTGF and CYR61 caught our attention. Both of CTGF and CYR61 belong to the CCN family (13, 23) . Members of this family stimulate mitosis, adhesion, extracellular matrix production, growth and migration in multiple cell types through their interaction with protein partners distributed in extracellular matrix and cell surface (22, 23) . Dysregulation of this family have been shown in a number of cancers, such as breast and ovarian cancers (30, 31) . However, genes in this family appear to have different or even opposing functions in different cancers (32) .
Previous studies showed that CTGF was over-expressed in ESCCs and involved in the tumorigenicity of ESCC cells (19) . Our results confirmed up-regulation of CTGF in ESCCs, and we also found that CYR61 was over-expressed in ESCCs and participated in the regulation of proliferation and invasiveness. Moreover, restored expression of CYR61 or CTGF led to a partial recovery of the suppression of cellular proliferation and invasiveness induced by down-regulation of fascin expression.
Interestingly, over-expression of CTGF or CYR61 was also related to poor survival of patients with ESCC (data not shown). These results suggested that CTGF and CYR61 might be involved in the function of fascin in ESCC.
It was reported that CTGF and CYR61 were target genes of both TGF-β pathway and Wnt/β-catenin pathway (33) . We reported here that TGF-β, rather than Wnt pathway (data not shown) played predominant roles in the fascin-mediated alterations of CTGF and CYR61. Despite an established role in suppressing tumor formation, the TGF-β pathway can also stimulate tumor invasion (34) . In ESCC, TGF-β pathway was disturbed and the expression of TGF-β1 was up-regulated, which might be responsible for the high invasive capability of ESCC cells (35) (36) (37) . Our results showed that the activity of TGF-β pathway was decreased upon fascin depletion. CTGF and CYR61, downstream effectors of TGF-β action, were also down-regulated, and might influence the composition of microenvironment and cell-matrix interactions, which contributed to the alterations of cellular proliferation and invasiveness.
THBS1 is an extracellular matrix glycoprotein, which is thought to be a potential regulator of tumor growth and metastasis (38) . THBS1 is capable of activating TGF-β signal pathway, leading to transcription of Cyr61 and CTGF (39, 40) . Methylation-induced silencing of THBS1 expression correlated with impaired TGF-β signaling as indicated by decreased Smad2 phosphorylation and nuclear localization (41) . Specifically, we reported here down-regulation of THBS1 in the fascin-depleted cells. We also suggested that effects of fascin down-expression on the TGF-β pathway were possibly mediated by the decreased expression of THBS1. Furthermore, we observed that expression of THBS1 is up-regulated in cancerous tissues of ESCC and its expression pattern correlated with fascin over-expression, consistent with a potential involvement in the function of fascin (data not shown). Previous studies had showed that fascin was a critical component that was required for actin cytoskeletal organization and cell migration responses to THBS1 (42, 43) . However, how fascin affected the expression of THBS1 needed further study. Other than the regulation of THBS1 expression, fascin might influence TGF-β pathway by interaction with certain key component, and down-regulation of fascin altered the activation status of TGF-β pathway through its decreased interaction with this molecule. Further study to identify the hypothetical interaction is required.
In summary, our study reported fascin was up-regulated in ESCCs and over-expression of fascin was related to poor survival. We also found that fascin might affect the expressions of CYR61 and CTGF through TGF-β pathway and CYR61 and CTGF were directly involved in the fascin-mediated alterations of cellular proliferation and invasiveness. Taken Cell lines were as described in Figure 4 . 
